Cormorant Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,000
| Closed | -$7.95M | – | 44 |
|
|
2025
Q1 | $7.95M | Sell |
150,000
-250,000
| -63% | -$13.2M | 0.6% | 31 |
|
|
2024
Q4 | $22.4M | Hold |
400,000
| – | – | 1.23% | 23 |
|
|
2024
Q3 | $21M | Sell |
400,000
-75,000
| -16% | -$3.93M | 1.11% | 28 |
|
|
2024
Q2 | $19.5M | Sell |
475,000
-75,000
| -14% | -$3.08M | 1.13% | 27 |
|
|
2024
Q1 | $23.8M | Hold |
550,000
| – | – | 1.05% | 30 |
|
|
2023
Q4 | $25.3M | Sell |
550,000
-300,000
| -35% | -$13.8M | 1.21% | 26 |
|
|
2023
Q3 | $19.5M | Buy |
850,000
+250,000
| +42% | +$5.73M | 1.14% | 24 |
|
|
2023
Q2 | $9.89M | Buy |
+600,000
| New | +$9.89M | 0.55% | 38 |
|